CFG Pharma
0746.821.410 · rovalta.com · 25/09/2026
CFG Pharma
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCFG Pharma is a Private limited company incorporated in 2020. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Courcelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0746.821.410
- Incorporation
- 11/05/2020
- Legal form
- Private limited company
- Registered office
- Rue de Liège(CO) 2
6180 Courcelles · WallonieSee on map - Contributed capital
- 150 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -1,1 k € | +79.2% | -5,3 k € | +87.4% | -41,6 k € | +34.8% | -63,9 k € | +58.0% | -152 k € |
| EBITDA | -1,5 k € | +73.5% | -5,6 k € | +86.6% | -42 k € | +34.6% | -64,2 k € | +58.0% | -152,7 k € |
| Operating result | -11,5 k € | +26.5% | -15,6 k € | +69.9% | -52 k € | +29.9% | -74,2 k € | +54.2% | -161,9 k € |
| Net result | -28,5 k € | +10.3% | -31,8 k € | +47.7% | -60,8 k € | +18.1% | -74,3 k € | +54.1% | -162 k € |
| Balance sheet | |||||||||
| Equity | -207,3 k € | -15.9% | -178,8 k € | -21.6% | -147 k € | -70.5% | -86,2 k € | -621% | -12 k € |
| Total assets | 50,9 k € | -22.3% | 65,6 k € | -15.9% | 78 k € | -5.5% | 82,5 k € | -33.9% | 125 k € |
| Cash | 99,4 € | -97.7% | 4,3 k € | -36.3% | 6,8 k € | +291% | 1,7 k € | -94.5% | 31,3 k € |
| Debts | 245,4 k € | +2.2% | 240,2 k € | +6.8% | 225 k € | +33.3% | 168,8 k € | +23.3% | 136,9 k € |
Board of directors
Source · NBB, accounts to 31/12/20253 active · 2 ended
Active mandates
Ended mandates
Other companies at this address
Rue de Liège(CO) 2 6180 Courcelles| Company | CBE no. |
|---|---|
APR Pharma● Active | 0748.905.227 |
EYTELIA● Active | 0456.542.178 |
PHIDEX CALN● Active | 0632.516.214 |
sil'innov● Active | 0651.902.356 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 11/05/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 20 months |
| Filing date | 03/06/2026 | 25/06/2025 | 05/06/2024 | 19/06/2023 | 29/08/2022 |
| General meeting | 12/05/2026 | 13/05/2025 | 14/05/2024 | 09/05/2023 | 10/05/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 5 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 12/05/2026 | 03/06/2026 | French | |
| Abridged model | 31/12/2024 | 13/05/2025 | 25/06/2025 | French | |
| Abridged model | 31/12/2023 | 14/05/2024 | 05/06/2024 | French | |
| Micro model | 31/12/2022 | 09/05/2023 | 19/06/2023 | French | |
| Micro model | 31/12/2021 | 10/05/2022 | 29/08/2022 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-28,5 k €↑
- 2024Annual accounts 2024-31,8 k €↑
- 2023Annual accounts 2023-60,8 k €↑
- 2022Annual accounts 2022-74,3 k €↑
- 2021Annual accounts 2021-162 k €
- 11/05/2020IncorporationPrivate limited company